TD Cowen analyst Ritu Baral reiterated a Buy rating on Krystal Biotech today and set a price target of $202.00. The company’s shares closed toda...
TD Cowen analyst Ritu Baral reiterated a Buy rating on Krystal Biotech today and set a price target of $202.00. The company’s shares closed toda...